Endocrine resistant breast cancer cells with loss of ERα expression retain proliferative ability by reducing caspase7-mediated HDAC3 cleavage

S Yu, X Gong, Z Ma, M Zhang, L Huang, J Zhang… - Cellular Oncology, 2020 - Springer
ERα-caspase7-HDAC3 axis may play a role in promoting the proliferation of endocrine
resistant breast cancer cells. … report that endocrine resistant breast cancer cells with loss of ERα

[HTML][HTML] SERPINA3-ANKRD11-HDAC3 pathway induced aromatase inhibitor resistance in breast cancer can be reversed by HDAC3 inhibition

J Zhou, M Zhu, Q Wang, Y Deng, N Liu, Y Liu… - Communications …, 2023 - nature.com
… anti-proliferative effect in ER+ breast cancer than ER negative (… revealed a decrease of ERα
expression in LTED cells, when … a HDAC member, HDAC3, as a downstream target of ERα

[HTML][HTML] Nuclear mechanisms involved in endocrine resistance

J Dittmer - Frontiers in Oncology, 2021 - frontiersin.org
… -proliferative, ERα promotes proliferation. Estrogen-activated … Furthermore, inhibition of
HDAC3 was shown to reduce the … This leads to a γ-secretase-dependent cleavage of the Notch …

[HTML][HTML] Molecular mechanisms of anti-estrogen therapy resistance and novel targeted therapies

R Ozyurt, B Ozpolat - Cancers, 2022 - mdpi.com
… Inhibition of HDAC3 has significantly reduced the viability of ERα-deficient … /caspase 7/HDAC3
axis promotes the proliferation of endocrine-resistant BC cells that exhibit ERα loss [72]. …

The role of histone deacetylase 3 in breast cancer

R Rahbari, Y Rasmi, MH Khadem-Ansari, M Abdi - Medical Oncology, 2022 - Springer
… that decreasing HDAC3 cleavage in the absence of ERαproliferation of endocrine-resistant
breast cancer cells, and … endocrine-resistant breast cancers with low ERα expression. …

[PDF][PDF] Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies. Cancers 2022, 14, 5206

R Ozyurt, B Ozpolat - 2022 - researchgate.net
Endocrine resistant breast cancer cells with loss of ERα expression retain proliferative
ability by reducing caspase7-mediated HDAC3 cleavage. …

[HTML][HTML] EGR3 and estrone are involved in the tamoxifen resistance and progression of breast cancer

Y Xie, X Han, J Yu, M Yuan, Y Yan, J Qin, L Lan… - Journal of Cancer …, 2023 - Springer
… pathway of cell death induced by anti-cancer drug treatments, … , including cleaved caspase
3 and BAX, while decreasing the anti-… reported role of ERα in improving EGR3 expression, we …

Moscatilin suppresses the breast cancer both in vitro and in vivo by inhibiting HDAC3

W Su, L Zeng, W Chen - Dose-Response, 2021 - journals.sagepub.com
… -induced reduction of HDAC3, we detected the expression of … that breast cancer cells without
ERα expression can keep the … proliferation and increasing apoptosis of breast cancer cells. …

[HTML][HTML] Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies

C Thakur, Y Qiu, Y Fu, Z Bi, W Zhang, H Ji… - Frontiers in …, 2022 - frontiersin.org
… the pathogenesis of invasive breast cancer, reduced levels of … in ERα positive breast cancer
cells, while TNBC cells showed … the proliferation and motility of breast cancer cells (136–138)…

Selective HDAC3 Inhibitors with Potent In Vivo Antitumor Efficacy against Triple-Negative Breast Cancer

S Pulya, A Himaja, M Paul, N Adhikari… - Journal of Medicinal …, 2023 - ACS Publications
… inhibition or knockdown using siRNAs led to reduced ERα (… the protein expression levels
of caspase-3, caspase-7, cleaved … We have also examined the extent of cell proliferation by …